The report provides market dynamics and trends related to the global companion diagnostics market. In addition, it presents the market estimations and forecast of the market. The study estimates the revenue generated from the sales of companion diagnostics kits and does not include companion diagnostics service revenue. The valuations comprise revenue generated from companion diagnostics that are available for treatment of cancer, CNS disorders, infectious disease, and autoimmune disease. Furthermore, the report also excludes revenue generated from post-sale services of companion diagnostics. For the purpose of analysis, the global companion diagnostics market has been segmented based on technology type, indication, and region. The study estimates the revenue generated from the sales of companion diagnostic kits. On the basis of technology type, the market is categorized into immunohistochemistry, polymerase chain reaction (PCR), next generation sequencing (NGS), in situ hybridization, and others. Based on indication, the market is divided into oncology, neurology, and others. Oncology is further sub-segmented into lung cancer, colorectal cancer, breast cancer, blood cancer, and others. The report covers the revenue generated from the sales of products related to companion diagnostics systems offered in regions such as North America, Europe, Asia-Pacific, and LAMEA.

In a clinical laboratory, clinical pathology tests are carried out on collected clinical specimens, for obtaining information about the patient’s health, in order to aid in diagnosis, prevention, and treatment of diseases. The role of good quality management system is highly important to meet the international standards. This market in Nigeria is mainly driven by the growing burden of chronic diseases and increasing demand for accurate disease diagnosis, along with the government’s focus on public-private partnerships. However, factors, such as lack of medical laboratories, advanced diagnostic equipment, and inadequately trained laboratory staff are restraining the market’s growth.

Buildings use energy to maintain a comfortable and cool environment inside through cooling, ventilation, and heating of interior spaces as and when required. Besides, buildings also use energy to power home appliances, lighting systems, computers, and other office equipment. Energy use in buildings accounts for nearly 40% of the global energy consumption and 36% of the total energy-related carbon dioxide emission. These high percentages of energy usage and carbon dioxide emission need to be minimized to conserve more energy. The problem can be addressed by improving the efficiency of the equipment used inside buildings. This has increasingly led to the usage of plastic materials in buildings, as their usage has led to more energy conservation.

Buildings use energy to maintain a comfortable and cool environment inside through cooling, ventilation, and heating of interior spaces as and when required. Besides, buildings also use energy to power home appliances, lighting systems, computers, and other office equipment.  Energy use in buildings accounts for nearly 40% of the global energy consumption and 36% of the total energy-related carbon dioxide emission. These high percentages of energy usage and carbon dioxide emission need to be minimized to conserve more energy. The problem can be addressed by improving the efficiency of the equipment used inside buildings. This has increasingly led to the usage of plastic materials in buildings, as their usage has led to more energy conservation.